Houshiheisan promotes angiogenesis via HIF-1α/VEGF and SDF-1/CXCR4 pathways: in vivo and in vitro

Rationale: Houshiheisan (HSHS), a classic prescription in traditional Chinese medicine (TCM), has remarkable efficacy in the treatment of ischemic stroke. Objective: To investigate the pro-angiogenic effect and molecular mechanism of HSHS for stroke recovery. Methods and results: The rat permanent m...

Descripción completa

Detalles Bibliográficos
Autores principales: Xiang, Yangyang, Yao, Xiaoquan, Wang, Xuan, Zhao, Hui, Zou, Haiyan, Wang, Lei, Zhang, Qiu-Xia
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Portland Press Ltd. 2019
Materias:
Therapeutics & Molecular Medicine
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6822506/
https://www.ncbi.nlm.nih.gov/pubmed/31652450
http://dx.doi.org/10.1042/BSR20191006

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6822506/
https://www.ncbi.nlm.nih.gov/pubmed/31652450
http://dx.doi.org/10.1042/BSR20191006

Ejemplares similares